US Market Report for Dental Soft Tissue Regeneration 2017 - MedCore

US Market Report for Dental Soft Tissue Regeneration 2017 - MedCore

  • July 2017 •
  • 528 pages •
  • Report ID: 5011668 •
  • Format: PDF
General Report Contents
- Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
- Market Drivers & Limiters for each chapter segment
- Competitive Analysis for each chapter segment
- Section on recent mergers & acquisitions

An important distinction exists between dental soft tissue regeneration products and barrier membrane products. Barrier membranes, also known as dental membranes, are devices that are used during bone grafting procedures that are designed to promote guided bone regeneration (GBR). These devices fall into two main categories: resorbable membranes (including allografts and xenografts) and non-resorbable membranes (alloplasts).

The non-resorbable synthetic alloplast membranes must be removed in a separate procedure after the healing process is complete. Non-resorbable membranes were typically manufactured using synthetic materials such as polytetrafluoroethylene (PTFE). This type of membrane stays in place for 3 to 4 weeks, after which it must be removed by dentists. This provides sufficient time for the blood clot to form, graft material to consolidate and osseous tissue to begin forming under the membrane.

Resorbable membranes (allografts and xenografts) break down after four to twelve weeks depending on the membrane brand, and are absorbed into the body, eliminating the need for a second procedure. These barrier membrane products essentially function to protect the bone graft as it develops by acting as a barrier, preventing soft tissue from growing into the regenerating bone. Bone is anatomically classified as a mineralized tissue, which differs substantially in function compared to soft tissue. For this reason, barrier membranes will not be included in the analysis of this report. Only devices that are directly involved in facilitating the regeneration and remodeling of soft tissue are included in the analysis.

Dental soft tissue regeneration devices are used to facilitate the regeneration of soft tissue, either in response to soft tissue recession or during a dental implant procedure. Applications for the devices include soft tissue augmentation around dental implants, root coverage, gingival augmentation and soft tissue ridge augmentation. The two main classes of dental soft tissue regeneration products are allografts (human tissue-derived) and xenografts (non-human animal tissue-derived). This market does not include alloplasts, as these products fall into the barrier membrane category.